N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide

C50H65FN10O10S — CID 171408009

IUPACN-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide
SMILESCC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)cc1c2CCCCOCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)c1cnc(=S)[nH]c1)C(C)C
InChIInChI=1S/C50H65FN10O10S/c1-5-50(69)35-20-39-43-33(25-61(39)47(67)34(35)26-71-48(50)68)31(32-19-29(4)36(51)21-38(32)58-43)13-9-12-18-70-27-57-41(63)24-54-45(65)37(14-8-10-16-52)59-46(66)42(28(2)3)60-40(62)15-7-6-11-17-53-44(64)30-22-55-49(72)56-23-30/h19-23,28,37,42,69H,5-18,24-27,52H2,1-4H3,(H,53,64)(H,54,65)(H,57,63)(H,59,66)(H,60,62)(H,55,56,72)/t37-,42-,50+/m0/s1
InChIKeyKDTUCNODFSDSGL-SQDGKIBRSA-N
MW1017.19 g/mol
LogP3.25
Rot. Bonds26

About N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide

N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide (PubChem CID 171408009) has the molecular formula C50H65FN10O10S and a molecular weight of 1017.19 g/mol. Its IUPAC name is N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide.

Molecular Properties

Compound NameN-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide
PubChem CID171408009
Molecular FormulaC50H65FN10O10S
Molecular Weight1017.19 g/mol
Exact Mass1016.46
IUPAC NameN-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide
SMILESCC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)cc1c2CCCCOCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)c1cnc(=S)[nH]c1)C(C)C
InChIInChI=1S/C50H65FN10O10S/c1-5-50(69)35-20-39-43-33(25-61(39)47(67)34(35)26-71-48(50)68)31(32-19-29(4)36(51)21-38(32)58-43)13-9-12-18-70-27-57-41(63)24-54-45(65)37(14-8-10-16-52)59-46(66)42(28(2)3)60-40(62)15-7-6-11-17-53-44(64)30-22-55-49(72)56-23-30/h19-23,28,37,42,69H,5-18,24-27,52H2,1-4H3,(H,53,64)(H,54,65)(H,57,63)(H,59,66)(H,60,62)(H,55,56,72)/t37-,42-,50+/m0/s1
InChIKeyKDTUCNODFSDSGL-SQDGKIBRSA-N
XLogP3.25
TPSA290.85 Ų
H-Bond Donors8
H-Bond Acceptors15
Rotatable Bonds26
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001017.19
LogP ≤ 53.25
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide?
The IUPAC name of N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide (CID 171408009) is N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide.
What is the SMILES notation for N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide?
The canonical SMILES for N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide is CC[C@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)cc1c2CCCCOCNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CCCCCNC(=O)c1cnc(=S)[nH]c1)C(C)C.
What is the InChIKey of N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide?
The InChIKey is KDTUCNODFSDSGL-SQDGKIBRSA-N. The full InChI is InChI=1S/C50H65FN10O10S/c1-5-50(69)35-20-39-43-33(25-61(39)47(67)34(35)26-71-48(50)68)31(32-19-29(4)36(51)21-38(32)58-43)13-9-12-18-70-27-57-41(63)24-54-45(65)37(14-8-10-16-52)59-46(66)42(28(2)3)60-40(62)15-7-6-11-17-53-44(64)30-22-55-49(72)56-23-30/h19-23,28,37,42,69H,5-18,24-27,52H2,1-4H3,(H,53,64)(H,54,65)(H,57,63)(H,59,66)(H,60,62)(H,55,56,72)/t37-,42-,50+/m0/s1.
What are the key properties of N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide?
N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide has a molecular weight of 1017.19 g/mol, XLogP of 3.25, 26 rotatable bonds, 8 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[[(2S)-1-[[(2S)-6-amino-1-[[2-[4-[(19R)-19-ethyl-6-fluoro-19-hydroxy-7-methyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]butoxymethylamino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-6-oxohexyl]-2-sulfanylidene-1H-pyrimidine-5-carboxamide is sourced from PubChem (CID 171408009), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).